Goodwin advised GaeaStar on the deal. GaeaStar announced its $6.5 million seed funding round. The round was led by a family office focused on ethical investments and...
GaeaStar’s $6.5 Million Seed Funding
Fulcrum Therapeutics’ $125 Million Public Offering of Common Stock
Goodwin Procter advised Fulcrum Therapeutics on the deal. Fulcrum Therapeutics, Inc. (Nasdaq: FULC) announced its underwritten public offering of 9,615,384 shares of its common stock at...